Tag Archives: Merck

Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck

Merck’s Keytruda finally has some immuno-oncology competition in the previously untreated non-small cell lung cancer market, courtesy of Roche and its freshly minted Tecentriq-Avastin combo. Late Thursday, the FDA green-lighted the regimen—containing Roche’s PD-L1 drug Tecentriq, its older blockbuster Avastin and chemotherapy— for patients without EGFR or ALK mutations.  Even with an FDA okay in the bag, though, the real… Read More »

FDA approves two new HIV drugs from Merck

(Reuters) – Merck & Co Inc said on Thursday the U.S. Food And Drug Administration approved two of its HIV oral drugs, nearly two months ahead of schedule. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The drugs have been… Read More »